ClinicalTrials.Veeva

Menu

Evaluate Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore®) (antiadhesion)

Y

Yong Sang Song

Status and phase

Unknown
Phase 3

Conditions

Gynecologic Disease

Treatments

Device: Adept
Device: Mediclore

Study type

Interventional

Funder types

Other

Identifiers

NCT03007654
CG-AHS008

Details and patient eligibility

About

The purpose of this study is to evaluate the efficacy and safety of Mediclore®, as an antiadhesive barrier, which is made of Poloxamer, Gelatin and Chitosan.

Enrollment

192 estimated patients

Sex

Female

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with Gynecological disease (benign disease)
  • Patients who Written informed consent
  • Patients without clinically significant lab

Exclusion criteria

  • having enrolled another clinical trials within 1 month
  • Immunosuppression or autoimmune disease
  • Anticoagulant, general steroids within a week from surgery
  • Serious diseases (heart failure, renal failure, liver failure, uncontrolled hypertension, diabetes mellitus, coagulation deficiencies)
  • Patients with previous history of surgery at the same operate site

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

192 participants in 3 patient groups

Mediclore
Experimental group
Description:
adhesion barrier Mediclore 5cc, to apply medical device fully around surgery area
Treatment:
Device: Mediclore
No treatment
No Intervention group
Description:
standard treatment for surgery
Adept
Active Comparator group
Description:
adhesion barrier, Adept, to apply medical device fully around surgery area
Treatment:
Device: Adept

Trial contacts and locations

1

Loading...

Central trial contact

Maria Lee, MD; Yongsang Song, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems